| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.38 | 0.03 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.061 | 0.03 |